Medvi, a telehealth platform providing access to prescription GLP-1 medications, has expanded its doctor-led weight management services through its online platform, en-medvi.com. The service connects patients with licensed clinicians for virtual evaluation and, when appropriate, provides access to GLP-1 treatments such as semaglutide and tirzepatide delivered directly to the patient’s home.

The Medvi platform was developed to make medical weight management more accessible by combining telehealth consultations, digital patient tools, and coordinated pharmacy fulfillment in one system. Patients begin by completing an online health questionnaire, which is reviewed by a licensed medical provider. If approved, the provider determines whether GLP-1 therapy is appropriate and recommends a treatment plan based on the individual’s health profile.

More than 100,000 individuals have used MEDVi’s services, according to information provided by the company, reflecting growing public interest in telehealth-based weight management programs.

Doctor-Led Telehealth Model

Medvi operates as a telehealth service rather than a retail wellness program. Each patient receives a medical review before any prescription is issued. The platform offers two primary formats of GLP-1 therapy:

• Weekly injectable GLP-1 medication

• Daily oral GLP-1 tablets

In addition, Medvi can assist patients who require brand-name options such as Ozempic®, when available. Treatment selection and dosing are determined by a licensed clinician based on the patient’s intake and medical history.

All services are managed through the Medvi patient portal, where users can access treatment instructions, refill schedules, and support.

How the Medvi Program Works

The Medvi process is conducted entirely online. Patients first complete an eligibility questionnaire through en-medvi.com, providing information about health history, current medications, and weight management goals. A licensed provider reviews the submission and determines whether GLP-1 therapy is appropriate.

If approved, patients receive a personalized plan that includes dosing guidance and safety information. Medication is then shipped directly to the patient’s address by partner pharmacies. Ongoing communication, refill management, and progress tracking take place through the Medvi portal.

Pricing and Access

Medvi operates on a monthly subscription model. Pricing and treatment options are displayed to patients before enrollment within the portal.

According to the company, introductory pricing may begin at $179 for GLP-1 injections and $249 for GLP-1 tablets. Ongoing monthly rates typically vary by dose and format. Brand-name medications, when requested and available, are priced separately.

Monthly fees include medication, telehealth oversight, portal access, and shipping. Medvi operates as a cash-pay service and does not require insurance for participation.

Medication and Pharmacy Standards

Medvi works with licensed U.S. compounding pharmacies to fulfill prescriptions for semaglutide and tirzepatide when appropriate. Compounded medications are not FDA-approved in the same way as branded drugs but are prepared in regulated facilities according to pharmacy standards.

Prescriptions are issued only after a medical review. Medvi does not manufacture medication but coordinates between clinicians and pharmacy partners for fulfillment and patient support.

GLP-1 Therapy and Weight Management

GLP-1 medications are used in medical weight management because they mimic a naturally occurring hormone involved in appetite regulation, digestion, and blood sugar control. These medications are prescribed by clinicians to help support reduced appetite and improved metabolic regulation.

Clinical studies of GLP-1 medications have shown average weight changes in the range of 10 to 20 percent over time, depending on the medication and patient profile. Individual results vary, and Medvi emphasizes medical screening and ongoing monitoring as part of its program.

Telehealth Support and Patient Tools

Patients using Medvi have access to digital tools that allow them to track body weight, dosing schedules, and reported side effects. Support is available through messaging within the Medvi portal.

The platform is designed to provide continuity of care through regular check-ins, refill scheduling, and clinician oversight without requiring in-person visits.

About Medvi

Medvi is a telehealth platform that provides access to doctor-led GLP-1 weight management services through its website, en-medvi.com. The company connects patients with licensed healthcare providers for virtual evaluation and, when appropriate, coordinates prescription fulfillment through partner pharmacies. Medvi focuses on digital access, transparent pricing, and home delivery of treatment.

To learn more, visit https://en-medvi.com/

Media Contact
Company Name: Medvi
Contact Person: Support
Email: Send Email
Country: United States
Website: en-medvi.com